This release concludes that buproprion is the best antidepressant for most overweight people, but the claim could have been tempered with the inclusion of some of the study limitations.
The story relies heavily on anecdotes, and while these personal stories are weighed against the perspectives of outside researchers, with much research being cited, we are never given needed details on what that research contains.
Lacking independent sources and a robust discussion of the study’s limitations, this story was thin on any information not already provided in the news release.
This news release states that the public isn’t getting all available health information on smokeless tobacco products. Giving us some examples would have been a better service than scolding those accused of withholding information.
Tips for Understanding Studies